United States Healthcare Equipment & Supplies

Hologic Inc (HOLX)

Track

The most recent insider trading activity occurred on October 20, 2025, with Christiana Stamoulis executing planned and proposed sales totaling over $1 million. Prior significant transactions include large planned and proposed sales by Stephen P. MacMillan in September 2025 and Essex D. Mitchell in December 2024. A buy transaction by Martin D. Madaus was noted on May 7, 2025.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: HOLX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Stamoulis Christiana

2 sales — total 1,081,728 USD

Planned sale 20 Oct 2025

Value US$4,693,320.43 | Price 118.76 | Shares 63,476

Proposed sale 20 Oct 2025

Value US$624,554.50 | Price 333.70 | Shares 38,232

MACMILLAN STEPHEN P

Chairman, President and CEO

4 sales — total 18,532,666 USD

Planned sale 22 Sep 2025

Value US$1,913,775.81 | Price 466.68 | Shares 39,495

Planned sale 22 Sep 2025

Value US$304,682.90 | Price 14.43 | Shares 52,681

Planned sale 22 Sep 2025

Value US$1,470,731.20 | Price 66.13 | Shares 22,240

Proposed sale 22 Sep 2025

Value US$9,266,548.29 | Price 66.98 | Shares 138,358

Madaus Martin D

1 purchase — total 300,760 USD

Buy 7 May 2025

Value US$300,760.02 | Price 55.24 | Shares 5,445

Mitchell Essex D

Chief Operating Officer

2 sales — total 3,794,966 USD

Sale 4 Dec 2024

Value US$1,897,482.18 | Price 76.34 | Shares 24,856

Proposed sale 4 Dec 2024

Value US$1,897,483.61 | Price 76.34 | Shares 24,856

Oberton Karleen Marie

Chief Financial Officer

2 sales — total 8,487,320 USD

Planned sale 29 Aug 2024

Value US$4,243,662.20 | Price 80.56 | Shares 52,679

Proposed sale 29 Aug 2024

Value US$4,243,657.48 | Price 80.56 | Shares 52,679

Schnittker Brandon

Div. President, GYN Surgical

2 sales — total 79,119 USD

Sale 6 Aug 2024

Value US$39,559.41 | Price 83.11 | Shares 476

Proposed sale 6 Aug 2024

Value US$39,559.28 | Price 83.11 | Shares 476

COHN BENJAMIN JORDAN

Principal Accounting Officer

2 sales — total 835,144 USD

Planned sale 1 Aug 2024

Value US$417,569.98 | Price 81.99 | Shares 5,093

Proposed sale 1 Aug 2024

Value US$417,573.59 | Price 81.99 | Shares 5,093

MACMILLAN STEPHEN P

Chairman, President and CEO

4 sales — total 7,195,818 USD

Planned sale 30 Jul 2024

Value US$1,665,168.96 | Price 82.32 | Shares 20,228

Planned sale 30 Jul 2024

Value US$1,317,454.88 | Price 81.44 | Shares 16,177

Planned sale 30 Jul 2024

Value US$615,300.40 | Price 80.60 | Shares 7,634

Proposed sale 30 Jul 2024

Value US$3,597,893.71 | Price 81.70 | Shares 44,039

MACMILLAN STEPHEN P

Chairman, President and CEO

2 sales — total 588,444 USD

Planned sale 17 Jul 2024

Value US$294,222.67 | Price 80.13 | Shares 3,672

Proposed sale 17 Jul 2024

Value US$294,221.60 | Price 80.13 | Shares 3,672

Stamoulis Christiana

2 sales — total 1,437,201 USD

Planned sale 17 Jul 2024

Value US$718,600.50 | Price 79.50 | Shares 9,039

Proposed sale 17 Jul 2024

Value US$718,600.50 | Price 79.50 | Shares 9,039

GARRETT SCOTT T

2 sales — total 2,482,591 USD

Sale 14 Mar 2024

Value US$1,241,295.50 | Price 75.50 | Shares 16,441

Proposed sale 14 Mar 2024

Value US$1,241,295.50 | Price 75.50 | Shares 16,441

Dockendorff Charles J

2 sales — total 223,295 USD

Planned sale 8 Mar 2024

Value US$111,647.65 | Price 76.21 | Shares 1,465

Proposed sale 8 Mar 2024

Value US$111,647.65 | Price 76.21 | Shares 1,465

CRAWFORD SALLY

2 sales — total 1,381,217 USD

Sale 8 Mar 2024

Value US$690,606.72 | Price 76.40 | Shares 9,039

Proposed sale 8 Mar 2024

Value US$690,610.24 | Price 76.40 | Shares 9,039

Oberton Karleen Marie

Chief Financial Officer

2 sales — total 2,241,000 USD

Planned sale 29 Jan 2024

Value US$1,120,500.00 | Price 75.00 | Shares 14,940

Proposed sale 29 Jan 2024

Value US$1,120,500.00 | Price 75.00 | Shares 14,940

Dockendorff Charles J

2 sales — total 2,306,448 USD

Planned sale 2 Jan 2024

Value US$1,153,224.00 | Price 72.00 | Shares 16,017

Proposed sale 2 Jan 2024

Value US$1,153,224.00 | Price 72.00 | Shares 16,017

GARRETT SCOTT T

2 sales — total 1,374,232 USD

Sale 11 Dec 2023

Value US$687,116.00 | Price 68.71 | Shares 10,000

Proposed sale 11 Dec 2023

Value US$687,115.74 | Price 68.71 | Shares 10,000

MACMILLAN STEPHEN P

Chairman, President and CEO

2 sales — total 6,701,821 USD

Planned sale 29 Nov 2023

Value US$3,359,188.38 | Price 70.41 | Shares 47,711

Proposed sale 29 Nov 2023

Value US$3,342,632.66 | Price 70.06 | Shares 47,711

Mitchell Essex D

Div. President, GYN Surgical

2 sales — total 1,077,782 USD

Sale 21 Nov 2023

Value US$538,890.00 | Price 71.85 | Shares 7,500

Proposed sale 21 Nov 2023

Value US$538,892.19 | Price 71.85 | Shares 7,500

GARRETT SCOTT T

2 sales — total 1,594,479 USD

Sale 15 Jun 2023

Value US$797,240.00 | Price 79.72 | Shares 10,000

Proposed sale 15 Jun 2023

Value US$797,238.85 | Price 79.72 | Shares 10,000

Thornal Kevin R

Officer

1 sale — total 6,122,598 USD

Proposed sale 9 May 2023

Value US$6,122,598.19 | Price 84.99 | Shares 72,041

Mitchell Essex D

Div. President, GYN Surgical

2 sales — total 400,231 USD

Planned sale 5 May 2023

Value US$200,115.18 | Price 83.73 | Shares 2,390

Proposed sale 5 May 2023

Value US$200,115.49 | Price 83.73 | Shares 2,390

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 778,445 USD

Planned sale 7 Feb 2023

Value US$778,444.97 | Price 85.28 | Shares 9,128

Hellmann Elisabeth A

SVP, Human Resources

1 sale — total 125,984 USD

Sale 14 Dec 2022

Value US$125,983.60 | Price 76.40 | Shares 1,649

MACMILLAN STEPHEN P

Chairman, President and CEO

2 sales — total 2,534,365 USD

Sale 30 Nov 2022

Value US$950,326.02 | Price 76.02 | Shares 12,501

Sale 30 Nov 2022

Value US$1,584,038.57 | Price 75.43 | Shares 20,999

Thornal Kevin R

Group Pres, Global Diagnostics

2 sales — total 1,440,062 USD

Sale 15 Nov 2022

Value US$940,509.49 | Price 75.30 | Shares 12,490

Sale 15 Nov 2022

Value US$499,552.36 | Price 75.37 | Shares 6,628

Griffin John M.

General Counsel

2 sales — total 2,047,888 USD

Sale 14 Nov 2022

Value US$249,979.12 | Price 76.49 | Shares 3,268

Sale 14 Nov 2022

Value US$1,797,909.28 | Price 76.07 | Shares 23,634

MACMILLAN STEPHEN P

Chairman, President and CEO

3 sales — total 10,479,378 USD

Sale 11 Nov 2022

Value US$3,257,294.42 | Price 75.94 | Shares 42,893

Sale 11 Nov 2022

Value US$3,969,564.00 | Price 75.57 | Shares 52,529

Sale 11 Nov 2022

Value US$3,252,520.00 | Price 75.64 | Shares 43,000

Oberton Karleen Marie

Chief Financial Officer

1 sale — total 1,054,513 USD

Planned sale 1 Nov 2022

Value US$1,054,512.50 | Price 72.50 | Shares 14,545

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 302,730 USD

Sale 17 May 2022

Value US$302,730.38 | Price 78.75 | Shares 3,844

Verstreken Jan

Group President, International

1 sale — total 512,168 USD

Sale 17 May 2022

Value US$512,167.50 | Price 78.80 | Shares 6,500

COHN BENJAMIN JORDAN

Principal Accounting Officer

2 sales — total 532,365 USD

Sale 13 May 2022

Value US$290,032.58 | Price 75.49 | Shares 3,842

Sale 13 May 2022

Value US$242,332.53 | Price 75.49 | Shares 3,210

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 161,564 USD

Planned sale 3 May 2022

Value US$161,564.04 | Price 74.18 | Shares 2,178

Daugherty Sean S.

Group President, BSH & Surg.

1 sale — total 155,016 USD

Sale 24 Feb 2022

Value US$155,016.24 | Price 71.14 | Shares 2,179

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 194,791 USD

Sale 19 Nov 2021

Value US$194,790.58 | Price 75.79 | Shares 2,570

Daugherty Sean S.

Group President, BSH & Surg.

1 sale — total 260,149 USD

Sale 10 May 2021

Value US$260,149.02 | Price 65.02 | Shares 4,001

Bebo Allison P

SVP, Human Resources

1 sale — total 512,778 USD

Sale 5 Feb 2021

Value US$512,778.20 | Price 84.06 | Shares 6,100

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 707,867 USD

Planned sale 4 Feb 2021

Value US$707,866.76 | Price 84.31 | Shares 8,396

Thornal Kevin R

Div. President, Diagnostics

2 sales — total 1,248,212 USD

Sale 10 Dec 2020

Value US$683,408.58 | Price 73.99 | Shares 9,236

Sale 10 Dec 2020

Value US$564,803.84 | Price 74.00 | Shares 7,633

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 108,759 USD

Sale 10 Dec 2020

Value US$108,758.90 | Price 73.64 | Shares 1,477

Griffin John M.

General Counsel

2 sales — total 1,627,689 USD

Sale 18 Nov 2020

Value US$826,207.97 | Price 71.35 | Shares 11,579

Sale 18 Nov 2020

Value US$801,481.52 | Price 70.80 | Shares 11,321

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 362,900 USD

Sale 17 Nov 2020

Value US$362,900.00 | Price 72.58 | Shares 5,000

COHN BENJAMIN JORDAN

Principal Accounting Officer

1 sale — total 461,846 USD

Sale 12 Nov 2020

Value US$461,845.57 | Price 70.60 | Shares 6,542

Stamoulis Christiana

1 sale — total 824,804 USD

Planned sale 4 Nov 2020

Value US$824,804.00 | Price 74.00 | Shares 11,146

Oberton Karleen Marie

Chief Financial Officer

1 sale — total 937,500 USD

Planned sale 21 Sep 2020

Value US$937,500.00 | Price 62.50 | Shares 15,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-10-22	2025-10-20	PlS Planned sale	Stamoulis Christiana Non-Executive Director	63,476 +7.3% 118.76 US$4,693,320	63,476 +7.3%	118.76	US$4,693,320
2025-10-20	2025-10-20	PrS Proposed sale	Stamoulis Christiana Director Non-Executive Director	38,232 333.70 US$624,555	38,232	333.70	US$624,555
2025-09-23	2025-09-22	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	39,495 -15.8% 466.68 US$1,913,776	39,495 -15.8%	466.68	US$1,913,776
2025-09-23	2025-09-22	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	77,418 -5.7% 67.04 US$5,190,103	77,418 -5.7%	67.04	US$5,190,103
2025-09-23	2025-09-22	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	22,240 -1.6% 66.13 US$1,470,731	22,240 -1.6%	66.13	US$1,470,731
2025-09-22	2025-09-22	PrS Proposed sale	2.1 MACMILLAN STEPHEN P Officer; Director Executive Director	138,358 66.98 US$9,266,548	138,358	66.98	US$9,266,548
2025-05-09	2025-05-07	B Purchase	4.1 Madaus Martin D Non-Executive Director	5,445 +inf% 55.24 US$300,760	5,445 +inf%	55.24	US$300,760
2024-12-06	2024-12-04	S Sale	3.2 Mitchell Essex D Chief Operating Officer Officer	24,856 -47.1% 76.34 US$1,897,482	24,856 -47.1%	76.34	US$1,897,482
2024-12-04	2024-12-04	PrS Proposed sale	3.2 Mitchell Essex D Officer Officer	24,856 76.34 US$1,897,484	24,856	76.34	US$1,897,484
2024-09-03	2024-08-29	PlS Planned sale	Oberton Karleen Marie Chief Financial Officer Officer	52,679 -38.5% 80.56 US$4,243,662	52,679 -38.5%	80.56	US$4,243,662
2024-08-29	2024-08-29	PrS Proposed sale	Oberton Karleen Marie Officer Officer	52,679 80.56 US$4,243,657	52,679	80.56	US$4,243,657
2024-08-08	2024-08-06	S Sale	2.2 Schnittker Brandon Div. President, GYN Surgical Officer	476 -11.3% 83.11 US$39,559	476 -11.3%	83.11	US$39,559
2024-08-06	2024-08-06	PrS Proposed sale	2.2 Schnittker Brandon Officer Officer	476 83.11 US$39,559	476	83.11	US$39,559
2024-08-05	2024-08-01	PlS Planned sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	5,093 -32.7% 81.99 US$417,570	5,093 -32.7%	81.99	US$417,570
2024-08-01	2024-08-01	PrS Proposed sale	2.9 COHN BENJAMIN JORDAN Officer Officer	5,093 81.99 US$417,574	5,093	81.99	US$417,574
2024-08-01	2024-07-30	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	20,228 -1.7% 82.32 US$1,665,169	20,228 -1.7%	82.32	US$1,665,169
2024-08-01	2024-07-30	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	16,177 -1.4% 81.44 US$1,317,455	16,177 -1.4%	81.44	US$1,317,455
2024-08-01	2024-07-30	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	7,634 -0.6% 80.60 US$615,300	7,634 -0.6%	80.60	US$615,300
2024-07-30	2024-07-30	PrS Proposed sale	2.1 MACMILLAN STEPHEN P Officer; Director Executive Director	44,039 81.70 US$3,597,894	44,039	81.70	US$3,597,894
2024-07-19	2024-07-17	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	3,672 -0.3% 80.13 US$294,223	3,672 -0.3%	80.13	US$294,223
2024-07-19	2024-07-17	PlS Planned sale	Stamoulis Christiana Non-Executive Director	9,039 -16.6% 79.50 US$718,600	9,039 -16.6%	79.50	US$718,600
2024-07-17	2024-07-17	PrS Proposed sale	2.1 MACMILLAN STEPHEN P Officer; Director Executive Director	3,672 80.13 US$294,222	3,672	80.13	US$294,222
2024-07-17	2024-07-17	PrS Proposed sale	Stamoulis Christiana Director Non-Executive Director	9,039 79.50 US$718,600	9,039	79.50	US$718,600
2024-03-15	2024-03-14	S Sale	2.5 GARRETT SCOTT T Non-Executive Director	16,441 -25.3% 75.50 US$1,241,296	16,441 -25.3%	75.50	US$1,241,296
2024-03-14	2024-03-14	PrS Proposed sale	2.5 GARRETT SCOTT T Director Non-Executive Director	16,441 75.50 US$1,241,296	16,441	75.50	US$1,241,296
2024-03-11	2024-03-08	PlS Planned sale	3.8 Dockendorff Charles J Non-Executive Director	1,465 -48.2% 76.21 US$111,648	1,465 -48.2%	76.21	US$111,648
2024-03-11	2024-03-08	S Sale	2.2 CRAWFORD SALLY Non-Executive Director	9,039 -6.4% 76.40 US$690,607	9,039 -6.4%	76.40	US$690,607
2024-03-08	2024-03-08	PrS Proposed sale	2.2 CRAWFORD SALLY Director Non-Executive Director	9,039 76.40 US$690,610	9,039	76.40	US$690,610
2024-03-08	2024-03-08	PrS Proposed sale	3.8 Dockendorff Charles J Director Non-Executive Director	1,465 76.21 US$111,648	1,465	76.21	US$111,648
2024-01-30	2024-01-29	PlS Planned sale	Oberton Karleen Marie Chief Financial Officer Officer	14,940 -12.6% 75.00 US$1,120,500	14,940 -12.6%	75.00	US$1,120,500
2024-01-29	2024-01-29	PrS Proposed sale	Oberton Karleen Marie Officer Officer	14,940 75.00 US$1,120,500	14,940	75.00	US$1,120,500
2024-01-04	2024-01-02	PlS Planned sale	3.8 Dockendorff Charles J Non-Executive Director	16,017 -91.6% 72.00 US$1,153,224	16,017 -91.6%	72.00	US$1,153,224
2024-01-02	2024-01-02	PrS Proposed sale	3.8 Dockendorff Charles J Director Non-Executive Director	16,017 72.00 US$1,153,224	16,017	72.00	US$1,153,224
2023-12-13	2023-12-11	S Sale	2.5 GARRETT SCOTT T Non-Executive Director	10,000 -17.5% 68.71 US$687,116	10,000 -17.5%	68.71	US$687,116
2023-12-11	2023-12-11	PrS Proposed sale	2.5 GARRETT SCOTT T Director Non-Executive Director	10,000 68.71 US$687,116	10,000	68.71	US$687,116
2023-12-01	2023-11-29	PlS Planned sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	47,711 -3.7% 70.41 US$3,359,188	47,711 -3.7%	70.41	US$3,359,188
2023-11-29	2023-11-29	PrS Proposed sale	2.1 MACMILLAN STEPHEN P Officer; Director Executive Director	47,711 70.06 US$3,342,633	47,711	70.06	US$3,342,633
2023-11-24	2023-11-21	S Sale	3.2 Mitchell Essex D Div. President, GYN Surgical Officer	7,500 -36.9% 71.85 US$538,890	7,500 -36.9%	71.85	US$538,890
2023-11-21	2023-11-21	PrS Proposed sale	3.2 Mitchell Essex D Officer Officer	7,500 71.85 US$538,892	7,500	71.85	US$538,892
2023-06-20	2023-06-15	S Sale	2.5 GARRETT SCOTT T Non-Executive Director	10,000 -14.9% 79.72 US$797,240	10,000 -14.9%	79.72	US$797,240
2023-06-15	2023-06-15	PrS Proposed sale	2.5 GARRETT SCOTT T Director Non-Executive Director	10,000 79.72 US$797,239	10,000	79.72	US$797,239
2023-05-09	2023-05-09	PrS Proposed sale	2.2 Thornal Kevin R Officer Officer	72,041 84.99 US$6,122,598	72,041	84.99	US$6,122,598
2023-05-09	2023-05-05	PlS Planned sale	3.2 Mitchell Essex D Div. President, GYN Surgical Officer	2,390 -24.9% 83.73 US$200,115	2,390 -24.9%	83.73	US$200,115
2023-05-05	2023-05-05	PrS Proposed sale	3.2 Mitchell Essex D Officer Officer	2,390 83.73 US$200,115	2,390	83.73	US$200,115
2023-02-09	2023-02-07	PlS Planned sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	9,128 -39.0% 85.28 US$778,445	9,128 -39.0%	85.28	US$778,445
2022-12-16	2022-12-14	S Sale	0.9 Hellmann Elisabeth A SVP, Human Resources Officer	1,649 -16.2% 76.40 US$125,984	1,649 -16.2%	76.40	US$125,984
2022-12-02	2022-11-30	S Sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	12,501 -0.5% 76.02 US$950,326	12,501 -0.5%	76.02	US$950,326
2022-12-02	2022-11-30	S Sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	20,999 -0.9% 75.43 US$1,584,039	20,999 -0.9%	75.43	US$1,584,039
2022-11-17	2022-11-15	S Sale	2.2 Thornal Kevin R Group Pres, Global Diagnostics Officer	12,490 -16.7% 75.30 US$940,509	12,490 -16.7%	75.30	US$940,509
2022-11-17	2022-11-15	S Sale	2.2 Thornal Kevin R Group Pres, Global Diagnostics Officer	6,628 -9.6% 75.37 US$499,552	6,628 -9.6%	75.37	US$499,552
2022-11-16	2022-11-14	S Sale	1.9 Griffin John M. General Counsel Officer	3,268 -1.9% 76.49 US$249,979	3,268 -1.9%	76.49	US$249,979
2022-11-16	2022-11-14	S Sale	1.9 Griffin John M. General Counsel Officer	23,634 -12.1% 76.07 US$1,797,909	23,634 -12.1%	76.07	US$1,797,909
2022-11-14	2022-11-11	S Sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	42,893 -1.7% 75.94 US$3,257,294	42,893 -1.7%	75.94	US$3,257,294
2022-11-14	2022-11-11	S Sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	52,529 -2.1% 75.57 US$3,969,564	52,529 -2.1%	75.57	US$3,969,564
2022-11-14	2022-11-11	S Sale	2.1 MACMILLAN STEPHEN P Chairman, President and CEO Executive Director	43,000 -1.7% 75.64 US$3,252,520	43,000 -1.7%	75.64	US$3,252,520
2022-11-03	2022-11-01	PlS Planned sale	Oberton Karleen Marie Chief Financial Officer Officer	14,545 -10.3% 72.50 US$1,054,512	14,545 -10.3%	72.50	US$1,054,512
2022-05-19	2022-05-17	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	3,844 -22.1% 78.75 US$302,730	3,844 -22.1%	78.75	US$302,730
2022-05-19	2022-05-17	S Sale	3.0 Verstreken Jan Group President, International Officer	6,500 -9.2% 78.80 US$512,168	6,500 -9.2%	78.80	US$512,168
2022-05-17	2022-05-13	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	3,842 -22.1% 75.49 US$290,033	3,842 -22.1%	75.49	US$290,033
2022-05-17	2022-05-13	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	3,210 -19.2% 75.49 US$242,333	3,210 -19.2%	75.49	US$242,333
2022-05-05	2022-05-03	PlS Planned sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	2,178 -13.9% 74.18 US$161,564	2,178 -13.9%	74.18	US$161,564
2022-02-28	2022-02-24	S Sale	1.9 Daugherty Sean S. Group President, BSH & Surg. Officer	2,179 -4.3% 71.14 US$155,016	2,179 -4.3%	71.14	US$155,016
2021-11-23	2021-11-19	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	2,570 -14.1% 75.79 US$194,791	2,570 -14.1%	75.79	US$194,791
2021-05-12	2021-05-10	S Sale	1.9 Daugherty Sean S. Group President, BSH & Surg. Officer	4,001 -13.1% 65.02 US$260,149	4,001 -13.1%	65.02	US$260,149
2021-02-09	2021-02-05	S Sale	3.2 Bebo Allison P SVP, Human Resources Officer	6,100 -14.6% 84.06 US$512,778	6,100 -14.6%	84.06	US$512,778
2021-02-08	2021-02-04	PlS Planned sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	8,396 -33.5% 84.31 US$707,867	8,396 -33.5%	84.31	US$707,867
2020-12-14	2020-12-10	S Sale	2.2 Thornal Kevin R Div. President, Diagnostics Officer	9,236 -21.8% 73.99 US$683,409	9,236 -21.8%	73.99	US$683,409
2020-12-14	2020-12-10	S Sale	2.2 Thornal Kevin R Div. President, Diagnostics Officer	7,633 -18.7% 74.00 US$564,804	7,633 -18.7%	74.00	US$564,804
2020-12-14	2020-12-10	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	1,477 -8.2% 73.64 US$108,759	1,477 -8.2%	73.64	US$108,759
2020-11-20	2020-11-18	S Sale	1.9 Griffin John M. General Counsel Officer	11,579 -7.9% 71.35 US$826,208	11,579 -7.9%	71.35	US$826,208
2020-11-20	2020-11-18	S Sale	1.9 Griffin John M. General Counsel Officer	11,321 -7.2% 70.80 US$801,482	11,321 -7.2%	70.80	US$801,482
2020-11-19	2020-11-17	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	5,000 -21.5% 72.58 US$362,900	5,000 -21.5%	72.58	US$362,900
2020-11-16	2020-11-12	S Sale	2.9 COHN BENJAMIN JORDAN Principal Accounting Officer Officer	6,542 -26.0% 70.60 US$461,846	6,542 -26.0%	70.60	US$461,846
2020-11-06	2020-11-04	PlS Planned sale	Stamoulis Christiana Non-Executive Director	11,146 -22.1% 74.00 US$824,804	11,146 -22.1%	74.00	US$824,804
2020-09-23	2020-09-21	PlS Planned sale	Oberton Karleen Marie Chief Financial Officer Officer	15,000 -34.1% 62.50 US$937,500	15,000 -34.1%	62.50	US$937,500